Survival and treatment for colorectal cancer medicare patients in two group/staff health maintenance organizations and the fee-for-service setting

Medical Care Research and Review

Volumn 56, Issue 2, 1999, Pages 177-196

  Merrill, Ray M ^a   Brown, Martin L ^a   Potosky, Arnold L ^a   Riley, Gerald ^a   Taplin, Stephen H ^a   Barlow, William ^a   Fireman, Bruce H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL SURGERY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MEDICARE; TREATMENT OUTCOME;

EID: 0033023424     PISSN: 10775587     EISSN: None     Source Type: Journal    
DOI: 10.1177/107755879905600204     Document Type: Article

References (63)

1. Beahrs, O. H., D. E. Henson, R.V.P. Hutter, and B. J. Kennedy. 1992. Manual for Staging of Cancer. 4th ed. Philadelphia: J. B. Lippincott.
2. Beahrs, O. H., D. E. Henson, R.V.P. Hutter, and M. H. Myers. 1988. Manual for Staging of Cancer. 3d ed. Philadelphia: J. B. Lippincott.
3. Brook, R. H., C. J. Kamberg, and E. A. McGlynn. 1996. Health system reform and quality. Journal of the American Medical Association 276:476-80.
4. Brown, M. L., A. L. Potosky, G. B. Thompson, and L. G. Kessler. 1990. The knowledge and use of screening tests for colorectal and prostate cancer: Data from the 1987 National Health Interview Survey. Preventive Medicine 19:562-74.
5. Brown, R. S., J. W. Bergeron, D. G. Clement, J. W. Hill, and S. M. Retchin. 1993. The Medicare Risk Program for HMOs - Final Summary Report on Findings from the Evaluation. Final Report under HCFA Contract Number 500-8-0006. Princeton, NJ. Mathematica Policy Research, Inc.
6. Burt, R. W., and G. M. Petersen. 1996. Familial colorectal cancer: Diagnosis and management. In Prevention and early detection of colorectal cancer, edited by G. P. Young, P. Rozen, and B. Levin. Philadelphia: W. B. Saunders.
7. Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease 40:373-83.
8. Chow, W.-H., and S. S. Devesa. 1992. Death certificate reporting of colon and rectal cancers. Journal of the American Medical Association 267:3028.
9. Clancy, C. M., and H. Brody. 1995. Managed care: Jekyll or Hyde? Journal of the American Medical Association 273:338-9.
10. Clement, D. G., S. M. Retchin, R. S. Brown, and M. H. Stegall. 1994. Access and outcomes of elderly patients enrolled in managed care. Journal of the American Medical Association 271:1487-92.
11. Deans, G. T., C. C. Patterson, T. G. Parks, R. A. Spence, M. Heatley, R. J. Moorehead, and B. J. Rowlands. 1994. Colorectal carcinoma: Importance of clinical and pathological factors in survival. Annals of the Royal College of Surgeons of England 76:59-64.
12. Deyo, R. A., D. C. Cherkin, and M. A. Ciol. 1992. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 45:613-9.
13. Donabedian A. 1988. The quality of care. How can it be assessed? Journal of the American Medical Association 260:1743-48.
14. Dunst, J., and R. Sauer. 1994. The adjuvant therapy of rectal carcinoma: Its current status. Strahlentherapie und Onkologie 170:375-82.
15. Engstrom, P. F., A. B. Benson III, A. Cohen, J. Doroshow, K. Kiel, J. Niederhuber, M. Roh, and M. Tempero. 1996. NCCN colorectal cancer practice guidelines. The National Comprehensive Cancer Network. Oncology 10:140-75.
16. Farrow, D. C., J. M. Samet, W. C. Hunt. 1996. Regional variation in survival following the diagnosis of cancer. Journal of Clinical Epidemiology 49:843-7.
17. Fienberg, S. E. 1977. The analysis of cross-classification data. Cambridge, MA: MIT Press.
18. Fishman, P. A., and E. H. Wagner. 1998. Managed care data and public health: The experience of Group Health Cooperative of Puget Sound. Annual Review of Public Health 19:477-91.
19. Friedman, G. D., M. F. Collen, and B. H. Fireman. 1986. Multiphasic health checkup evaluation: A 16-year follow-up. Journal of Chronic Disease 39:453-63.
20. Gelb, A. B., and T. R. Schrock. 1997. Prognostic factors in colorectal carcinomas. Surgical Oncology Clinics of North America 6:463-94.
21. Greenfield, S., W. Rogers, M. Mangotich, M. F. Carney, and A. R. Tarlov. 1995. Outcomes of patients with hypertension and non-insulin-dependent diabetes mellitus treated by different systems and specialties. Journal of the American Medical Association 274:1436-44.
22. Greenwald, H. P., and C. J. Henke. 1992. HMO membership, treatment, and mortality risk among prostatic cancer patients. American Journal of Pubic Health 82:1099-104.
23. Hardcastle, J. D., J. O. Chamberlain, M. H. Robinson, S. M. Moss, S. S. Amar, T. W. Balfour, P. D. James, and C. M. Mangham. 1996. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472-7.
24. Harlan, L., O. Brawley, F. Pommerenke, P. Wali, and B. Kramer. 1995. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. Journal of Clinical Oncology 13:93-100.
25. Health Care Financing Administration. 1997. Medicare prepaid health plans monthly report, December 1994 and January 1997. Baltimore: Author.
26. Kalbfleisch, J. D., and R. L. Prentice. 1980. The statistical analysis of failure time data. New York: John Wiley.
27. Kassirer, J. P. 1996. The new health care game. New England Journal of Medicine 335:433.
28. Kronborg, O., C. Fenger, J. Olsen, O. D. Jorgensen, and O. Sondergaard. 1996. Randomised study of screening for colorectal cancer with faecal-occult-blood test [see comments]. Lancet 348:1467-71.
29. Kulkarni, P. R., S. V. Vernon, G. L. Jackson, D. Lairson, and B. R. Davis. 1989. Stage at diagnosis of breast cancer. Comparison in a fee-for-service and health maintenance organization practice. Medical Care 27:608-22.
30. Lane, P. W., and J. A. Nelder. 1982. Analysis of covariance and standardization as instances of prediction. Biometrics 38:613-21.
31. Lawrence, D. M., P. H. Mattingly, and J. M. Ludden. 1997. Trusting in the future: The distinct advantage of nonprofit HMOs. Milbank Quarterly 75:5-10.
32. Liu, S. K., J. M. Church, I. C. Lavery, and V. W. Fazio. 1997. Operation in patients with incurable colon cancer - is it worthwhile. Disease of the Colon & Rectum 40:11-4.
33. Lu-Yao, G. L., D. McLerran, J. Wasson, and J. E. Wennberg. 1993. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. Journal of the American Medical Association 269:2633-6.
34. Mandel, J. S., J. H. Bond, T. R. Church, D. C. Snover, G. M. Bradley, L. M. Schuman, and F. Ederer. 1993. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [published erratum appears in N Engl J Med 1993;329:672] [see comments]. New England Journal of Medicine 328:1365-71.
35. Middleton, G., and D. Cunningham. 1995. Current options in the management of gastrointestinal cancer. Annals of Oncology 6:17-25.
36. Miller, R. H., and H. S. Luft. 1997. Does managed care lead to better or worse quality of care? Health Affairs 16:7-25.
37. Moertel, C. G., T. R. Fleming, J. S. Macdonald, D. G. Haller, J. A. Laurie, C. M. Tangen, J. S. Ungerleider, W. A. Emerson, D. C. Tormey, J. H. Glick, M. H. Veeder, and J. A. Mailliard. 1995a. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Annals of Internal Medicine 122:321-6.
38. _. 1995b. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. Journal of Clinical Oncology 13:2936-43.
39. National Cancer Institute. 1989, April 4. Clinical announcement. Group C status of levamisole. Bethesda, MD: Author.
40. National Center for Health Statistics. 1997. Health, United States, 1996-97. Hyattsville, MD: Public health Service.
41. National Institutes of Health Consensus Conference. 1990. Adjuvant therapy for patients with colon and rectal cancer. Journal of the American Medical Association 264:1444-50.
42. Nelson, L., R. Brown, M. Gold, A. Ciemnecki, and E. Docteur. 1996. Access to care in Medicare HMO, 1996. Health Affairs 16:148-156.
43. Newcomb, P. A., R. G. Norfleet, B. E. Storer, T. S. Surawicz, and P. M. Marcus. 1992. Screening sigmoidoscopy and colorectal cancer mortality. Journal of the National Cancer Institute 84:1572-5.
44. Parker, S. L., T. Tong, S. Bolden, and P. A. Wingo. Cancer statistics 1997. 1997. CA Cancer Journal for Clinicians 47:5-27.
45. Percy, C., E. Stanek III, and L. Gloeckler. 1981. Accuracy of cancer death certificates and its effect on cancer mortality statistics. American Journal of Public Health 71:242-50.
46. Potosky, A. L., N. Breen, B. I. Graubard, and E. Parsons. 1998. The association between health care coverage and the use of cancer screening tests: Results from the 1992 National Health Interview Survey. Medical Care 36:257-70.
47. Potosky, A. L., R. M. Merrill, G. F. Riley, S. H. Taplin, W. Barlow, B. H. Fireman, and R. Ballard-Barbash. 1997. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. Journal of the National Cancer Institute 89:1683-91.
48. Potosky, A. L., R. M. Merrill, G. F. Riley, S. H. Taplin, W. Barlow, B. H. Fireman, and J. D. Lubitz. 1999. Prostate cancer treatment and 10-year survival among group/staff HMO and fee-for-service Medicare patients. Health Services Research 34:523-44.
49. Potosky, A. L., G. F. Riley, J. D. Lubitz, R. M. Mentnech, and L. G. Kessler. 1993. Potential for cancer related health services research using a linked Medicare-tumor registry database. Medical Care 31:732-48.
50. Prorok, P. C., R. J. Connor, S. G. Baker. 1990. Statistical considerations in cancer screening programs. Urologic Clinics of North America 17:699-708.
51. Retchin, S. M. 1997. Heterogeneity of health maintenance organizations and quality of care. Journal of the National Cancer Institute 89:1654-5.
52. Retchin, S. M., and B. Brown. 1990a. Management of colorectal cancer in Medicare health maintenance organizations [see comments]. Journal of General Internal Medicine 5:110-14.
53. Retchin, S. M., and B. Brown. 1990b. The quality of ambulatory care in Medicare health maintenance organizations [see comments]. American Journal of Public Health 80:411-15.
54. Retchin, S. M., R. S. Brown, S. J. Yeh, D. Chu, and L. Moreno. 1997. Outcomes of stroke patients in Medicare fee for service and managed care. Journal of the American Medical Association 278:119-24.
55. Ries, L. A. G., C. L. Kosary, B. F. Hankey, B. A. Miller, A. Harras, and B. K. Edwards, eds. 1997. SEER Cancer Statistics Review, 1973-1994: National Cancer Institute. NIH Pub. No. 97-2789. Bethesda, MD.
56. Riley, G. F., A. L. Potosky, J. D. Lubitz, and M. L. Brown. 1994. Stage of cancer at diagnosis for Medicare HMO and fee-for service enrollees [see comments]. American Journal of Public Health 84:1598-604.
57. Riley, G., C. Tudor, Y. P. Chiang, and M. Ingber. 1996. Health status of Medicare enrollees in HMOs and Fee-for-Service in 1994. Health Care Finance Review 17:65-76.
58. Satariano, W. A., and D. R. Ragland. 1994. The effect of comorbidity on 3-year survival of women with primary breast cancer. Annals of Internal Medicine 120:104-10.
59. Selby, J. V., G. D. Friedman, and M. F. Collen. 1988. Sigmoidoscopy and mortality from colorectal cancer: The Kaiser-Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology 41:427-34.
60. Selby, J. V., G. D. Friedman, C. P. Quesenberry Jr., and N. S. Weiss. 1992. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New England Journal of Medicine 326:653-7.
61. Wagner, E. H. 1996. The promise and performance of HMOs in improving outcomes in older adults. Journal of the American Geriatrics Society 44:1251-7.
62. West, D. W., W. A. Sateriano, D. R. Ragland, and R. A. Hiatt. 1996. Comorbidity and breast cancer survival: A comparison between black and white women. Annals of Epidemiology 6:413-9.
63. Winawer, S. J., B. J. Flehinger, D. Schottenfeld, and D. G. Miller. 1993. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. Journal of the National Cancer Institute 85:1311-8.